HCPCS Level IIdrugActive
J9354
Inj, ado-trastuzumab emt 1mg
BETOS: O1D
Effective: 2014-01-01
Description
Injection, ado-trastuzumab emtansine, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Kadcyla
Manufacturer
Genentech, Inc.
HCPCS Dosage
1 MG
Billing Units
160.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.